Trial · NCT04321031
Adverse event totals21
The totals the trial posted for each group.
1 to 20 of 21
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Placebo | 0 | 34 |
| Total, all-cause mortality | DGAT2i/PF-06865571 25 mg BID | 0 | 35 |
| Total, all-cause mortality | DGAT2i/PF-06865571 75 mg BID | 0 | 48 |
| Total, all-cause mortality | DGAT2i/PF-06865571 150 mg BID | 0 | 42 |
| Total, all-cause mortality | DGAT2i/PF-06865571 150 mg BID + ACCi/PF-05221304 5 mg BID | 0 | 35 |
| Total, all-cause mortality | DGAT2i/PF-06865571 300 mg BID | 0 | 31 |
| Total, all-cause mortality | DGAT2i/PF-06865571 300 mg BID + ACCi/PF-05221304 10 mg BID | 0 | 30 |
| Total, other adverse events | Placebo | 21 | 34 |
| Total, other adverse events | DGAT2i/PF-06865571 25 mg BID | 21 | 35 |
| Total, other adverse events | DGAT2i/PF-06865571 75 mg BID | 28 | 48 |
| Total, other adverse events | DGAT2i/PF-06865571 150 mg BID | 22 | 42 |
| Total, other adverse events | DGAT2i/PF-06865571 150 mg BID + ACCi/PF-05221304 5 mg BID | 19 | 35 |
| Total, other adverse events | DGAT2i/PF-06865571 300 mg BID | 19 | 31 |
| Total, other adverse events | DGAT2i/PF-06865571 300 mg BID + ACCi/PF-05221304 10 mg BID | 15 | 30 |
| Total, serious adverse events | Placebo | 1 | 34 |
| Total, serious adverse events | DGAT2i/PF-06865571 25 mg BID | 1 | 35 |
| Total, serious adverse events | DGAT2i/PF-06865571 75 mg BID | 5 | 48 |
| Total, serious adverse events | DGAT2i/PF-06865571 150 mg BID | 1 | 42 |
| Total, serious adverse events | DGAT2i/PF-06865571 150 mg BID + ACCi/PF-05221304 5 mg BID | 5 | 35 |
| Total, serious adverse events | DGAT2i/PF-06865571 300 mg BID | 4 | 31 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04321031/event-totals